BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Malfertheiner P, Selgrad M. Helicobacter pylori infection and current clinical areas of contention. Curr Opin Gastroenterol. 2010;26:618-623. [PMID: 20827182 DOI: 10.1097/mog.0b013e32833efede] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 El-Zimaity H, Serra S, Szentgyorgyi E, Vajpeyi R, Samani A. Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection. Can J Gastroenterol 2013;27:e25-30. [PMID: 24106732 DOI: 10.1155/2013/897423] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
2 Sereni G, Azzolini F, Camellini L, Formisano D, Decembrino F, Iori V, Tioli C, Cavina M, Di Mario F, Bedogni G, Sassatelli R. Efficacy of a therapeutic strategy for eradication of Helicobacter pylori infection. World J Gastroenterol 2012; 18(33): 4542-4548 [PMID: 22969227 DOI: 10.3748/wjg.v18.i33.4542] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lu B, Li M. Helicobacter pylori eradication for preventing gastric cancer. World J Gastroenterol 2014; 20(19): 5660-5665 [PMID: 24914325 DOI: 10.3748/wjg.v20.i19.5660] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
4 Choi IJ. Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer. Korean J Intern Med. 2013;28:525-537. [PMID: 24009446 DOI: 10.3904/kjim.2013.28.5.525] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
5 Ullah H, Di Minno A, Santarcangelo C, Khan H, Xiao J, Arciola CR, Daglia M. Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials. Molecules 2021;26:2272. [PMID: 33919894 DOI: 10.3390/molecules26082272] [Reference Citation Analysis]
6 Cardos IA, Zaha DC, Sindhu RK, Cavalu S. Revisiting Therapeutic Strategies for H. pylori Treatment in the Context of Antibiotic Resistance: Focus on Alternative and Complementary Therapies. Molecules 2021;26:6078. [PMID: 34641620 DOI: 10.3390/molecules26196078] [Reference Citation Analysis]
7 Jin S, Wu M, Cao H, Ying S, Hua J, Chen Y. p27(kip1) upregulated by hnRNPC1/2 antagonizes CagA (a virulence factor of Helicobacter pylori)-mediated pathogenesis. Helicobacter 2012;17:140-7. [PMID: 22404445 DOI: 10.1111/j.1523-5378.2011.00927.x] [Reference Citation Analysis]
8 Baeg MK, Choi MG, Ko SH, Lim CH, Kim JS, Cho YK, Park JM, Cho YS, Lee BI, Lee IS. Elderly women who received Helicobacter pylori-eradicating therapy have reduced risk of low skeletal muscle mass. Clin Interv Aging 2015;10:1771-7. [PMID: 26586939 DOI: 10.2147/CIA.S95007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
9 Miller AK, Williams SM. Helicobacter pylori infection causes both protective and deleterious effects in human health and disease. Genes Immun 2021;22:218-26. [PMID: 34244666 DOI: 10.1038/s41435-021-00146-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bridge DR, Merrell DS. Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease. Gut Microbes. 2013;4:101-117. [PMID: 23380646 DOI: 10.4161/gmic.23797] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
11 Sachs G, Scott DR. Helicobacter pylori: Eradication or Preservation. F1000 Med Rep 2012;4:7. [PMID: 22500191 DOI: 10.3410/M4-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
12 Greenberg ER, Anderson GL, Morgan DR, Torres J, Chey WD, Bravo LE, Dominguez RL, Ferreccio C, Herrero R, Lazcano-Ponce EC. 14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet. 2011;378:507-514. [PMID: 21777974 DOI: 10.1016/s0140-6736(11)60825-8] [Cited by in Crossref: 171] [Cited by in F6Publishing: 80] [Article Influence: 15.5] [Reference Citation Analysis]
13 Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16:1-9. [PMID: 21896079 DOI: 10.1111/j.1523-5378.2011.00874.x] [Cited by in Crossref: 172] [Cited by in F6Publishing: 174] [Article Influence: 15.6] [Reference Citation Analysis]
14 Mendoza E, Duque X, Hernández Franco JI, Reyes Maldonado E, Morán S, Martínez G, Salinas Rodríguez A, Martínez H. Association between Active H. pylori Infection and Iron Deficiency Assessed by Serum Hepcidin Levels in School-Age Children. Nutrients 2019;11:E2141. [PMID: 31500264 DOI: 10.3390/nu11092141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
15 Lee KJ. The Usefulness of Symptom-based Subtypes of Functional Dyspepsia for Predicting Underlying Pathophysiologic Mechanisms and Choosing Appropriate Therapeutic Agents. J Neurogastroenterol Motil 2021;27:326-36. [PMID: 34210898 DOI: 10.5056/jnm21042] [Reference Citation Analysis]
16 Goh KL, Chan WK, Shiota S, Yamaoka Y. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter. 2011;16 Suppl 1:1-9. [PMID: 21896079 DOI: 10.1111/j.1523-5378.2011.00874] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Ayala G, Escobedo-Hinojosa WI, Cruz-Herrera CFL, Romero I. Exploring alternative treatments for Helicobacter pylori infection. World J Gastroenterol 2014; 20(6): 1450-1469 [PMID: 24587621 DOI: 10.3748/wjg.v20.i6.1450] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 64] [Article Influence: 9.6] [Reference Citation Analysis]
18 O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Abnet CC. A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. Gut. 2012;61:1261-1268. [PMID: 22174193 DOI: 10.1136/gutjnl-2011-300551] [Cited by in Crossref: 88] [Cited by in F6Publishing: 79] [Article Influence: 8.0] [Reference Citation Analysis]
19 Fu HW. Helicobacter pylori neutrophil-activating protein: From molecular pathogenesis to clinical applications. World J Gastroenterol 2014; 20(18): 5294-5301 [PMID: 24833859 DOI: 10.3748/wjg.v20.i18.5294] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
20 Steffen A, Huerta JM, Weiderpass E, Bueno-de-Mesquita HB, May AM, Siersema PD, Kaaks R, Neamat-Allah J, Pala V, Panico S, Saieva C, Tumino R, Naccarati A, Dorronsoro M, Sánchez-Cantalejo E, Ardanaz E, Quirós JR, Ohlsson B, Johansson M, Wallner B, Overvad K, Halkjaer J, Tjønneland A, Fagherazzi G, Racine A, Clavel-Chapelon F, Key TJ, Khaw KT, Wareham N, Lagiou P, Bamia C, Trichopoulou A, Ferrari P, Freisling H, Lu Y, Riboli E, Cross AJ, Gonzalez CA, Boeing H. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2015;137:646-57. [PMID: 25598323 DOI: 10.1002/ijc.29432] [Cited by in Crossref: 52] [Cited by in F6Publishing: 45] [Article Influence: 7.4] [Reference Citation Analysis]
21 Hussain SA, Hamid S. Helicobacter pylori in humans: Where are we now? Adv Biomed Res 2014;3:63. [PMID: 24627871 DOI: 10.4103/2277-9175.125844] [Cited by in Crossref: 5] [Article Influence: 0.6] [Reference Citation Analysis]